Biotech

Biotech entrepreneur Dr. Shakked Halperin invests in next generation of Israeli scientists

While Israel continues to strengthen its position as a global innovation hub, access to educational opportunities that help develop future scientists and entrepreneurs remains relatively uneven.

From right to left: Yossi Halperin – Shakked’s father; Dr. Shakked Halperin – biotech entrepreneur, founder and CEO of the Shakked Halperin Foundation; Milene Halperin – Shakked’s mother.
Prof. Varda Shoshan-Barmatz in her lab at Ben-Gurion University of the Negev, where her research on the protein VDAC1 led to the founding of X-tosis.

Israeli man facing early-onset Alzheimer's develops potential treatment for Parkinson's disease

Bill Gates attends the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 21, 2026.

WATCH: AI could 'kill billions' if used by bad actors, Bill Gates warns

Harry Langbeheim in his home studio in Rehovot.

From Zurich to Rehovot: Harry Langbeheim’s paintings reveal the visual world of S.Y. Agnon


Trump administration works to strengthen defenses against potential AI bioattacks - report

The Trump administration is reviving biosecurity efforts years after slashing related government departments amid growing fears that AI could enable biological attacks.

Employees of the Research Institute for Protective Technologies, Nuclear, Biological and Chemical Protection (WIS) inspect a dummy sample which is contaminated with a substance similar to the chemical weapon Sarin, during a demonstration in Munster October 15, 2013.

Israeli plant-based protein co Plantopia raises $9m

The new funds will allow the company to move forward to the industrial production stage at a manufacturing plant currently under construction on Kibbutz Sdot Yam.

Mozzarella cheese produced by Plantopia.

Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada

D-PLEX100 is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent abdominal surgical site infections.

Medications. Ilustrative.

Israeli health-tech conference opens in Jerusalem with 1,800 participants from 40 countries

MIXiii Health-Tech.IL 2026 brought together investors, doctors, researchers, startups and global health-tech leaders, with a focus on Israeli emergency medicine, tech-bio, and technologies.

Jerusalem Mayor Moshe Lion, IATI CEO and President Karin Mayer Rubinstein and Teva executive Mark Sabag attend the opening of MIXiii Health-Tech.IL 2026 in Jerusalem.

Israeli life sciences investments fell 40% in 2025, report found

Investments in Israeli life sciences companies fell sharply in 2025, dropping 40% after a recovery the previous year, according to a report by the Israel Advanced Technology Industries Association.

In the photo (from left): Karin Mayer Rubinstein, CEO and President of the Israel Advanced Technology Industries Association (IATI), and Dror Bin, CEO of the Israel Innovation Authority.

Startup wants to grow “headless humans” to replace lab animals

Researchers describe brainless, lab-grown human bodies engineered to host full organ systems and study disease without consciousness.

 The four-story ‘Clore Person, with inflatable organs that are activated by climbing inside the giant statue

Israeli mathematician uses AI to decode human immune system

How an Israeli mathematician is using AI to decode the human immune system and transform patient treatment

Noam Solomon, CEO of Immunai, is using AI technology to map a key part of the human physiology – the immune system – and help discover and develop therapeutics that will ultimately save lives.

Israel's overlooked challenge: Environmental damage from two years of war - from the editor

As the war winds down, Israel faces a quieter crisis – environmental damage from Gaza to the Dead Sea, alongside long-neglected ecological failures now demanding urgent attention

Visitors walk across salt formations along the receding shoreline of the Dead Sea, a stark sign of the region’s growing environmental crisis.

Immunai, Bristol Myers Squibb sign AI immune-data collaboration

The New York-based AI biotech will use its AMICA-OS platform to analyze clinical immune data for BMS, aiming to inform patient stratification, biomarkers, and trial decisions.

 CEO and co-founder of Immunai Noam Solomon.

Israeli researchers develop SafeWax coating that could cut pesticide use by 50%

The team concluded that SafeWax is “an innovative technology with the potential to become a breakthrough in the field of sustainable crop protection.”

WORKERS TAKE care of cannabis plants at a farm in central Israel,  late last year.